Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 3:9:883181.
doi: 10.3389/fmed.2022.883181. eCollection 2022.

The Effect of Pregabalin on the Minimum Alveolar Concentration of Sevoflurane: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Affiliations

The Effect of Pregabalin on the Minimum Alveolar Concentration of Sevoflurane: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Johannes Müller et al. Front Med (Lausanne). .

Abstract

Background: Pregabalin is commonly used perioperatively to reduce post-operative pain and opioid consumption and to prevent the development of chronic pain. It has been shown to reduce anesthetic consumption in balanced anesthesia, but studies investigating its effect on the minimum alveolar concentration (MAC) of volatile anesthetics are lacking. The aim of this study was to investigate the effect of two different doses of pregabalin on the MAC of sevoflurane.

Methods: In a randomized, double-blinded, placebo controlled clinical study, 75 patients were assigned to receive placebo, 300 mg pregabalin, or 150 mg pregabalin, as a capsule 1 h before anesthesia induction with sevoflurane only. After equilibration, the response to skin incision (movement vs. non-movement) was monitored. The MAC was assessed using an up- and down-titration method.

Results: The MAC of sevoflurane was estimated as 2.16% (95% CI, 2.07-2.32%) in the placebo group, 1.44% (95% CI, 1.26-1.70%) in the 300 mg pregabalin group, and 1.81% (95% CI, 1.49-2.13%) in the 150 mg pregabalin group. We therefore report a 33% reduction in the MAC of sevoflurane in the 300 mg pregabalin group as compared to placebo. The MAC of the 150 mg pregabalin group was reduced by 16% as compared to placebo but was not statistically significant.

Conclusions: The administration of 300 mg pregabalin reduced the MAC of sevoflurane by 33%, while the administration of 150 mg pregabalin did not significantly reduce the MAC of sevoflurane. Pregabalin use led to a small reduction in post-operative pain levels but increased side effects in a dose-dependent manner.

Keywords: anesthesia; depth of anesthesia; minimum alveolar concentration (MAC); pregabalin; premedication before anesthesia; sevoflurane.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
CONSORT flow diagram. CONSORT, Consolidated standards of reporting trials. aReasons for exclusion: 4 patients received sedative premedication. bReasons for not receiving allocated intervention: 3 patients developed mild laryngospasm at induction that required intravenous anesthetics.
Figure 2
Figure 2
Titration process in the study groups. Circles indicate patients who moved, and rhombi indicate patients who did not move. Solid horizontal lines indicate the bootstrap estimates for the MAC, dashed horizontal lines indicate the 95% confidence intervals. MAC, minimum alveolar concentration.

Similar articles

References

    1. Lyrica . European Medicines Agency. Available online at: https://www.ema.europa.eu/en/medicines/human/EPAR/lyrica#product-informa... (accessed January 11, 2022).
    1. Joshi I, Taylor CP. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice. Eur J Pharmacol. (2006) 553:82–8. 10.1016/j.ejphar.2006.09.019 - DOI - PubMed
    1. Mishriky BM, Waldron NH, Habib AS. Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis. Br J Anaesth. (2015) 114:10–31. 10.1093/bja/aeu293 - DOI - PubMed
    1. Verret M, Lauzier F, Zarychanski R, Perron C, Savard X, Pinard AM, et al. . Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. (2020) 133:265–79. 10.1097/ALN.0000000000003428 - DOI - PubMed
    1. Eger EI, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentrationa standard of anesthetic potency. Anesthesiology. (1965) 26:756–63. 10.1097/00000542-196511000-00010 - DOI - PubMed

LinkOut - more resources